Comparing Post-Transplant Cyclophosphamide As GVHD Prophylaxis to Standard of Care for Acute Leukemia Patients
Abroad (travel likely)RecruitingPHASE3
Conditions
Acute Lymphoblastic Leukemia (ALL) in Complete Remission · Acute Myeloid Leukemia (AML) in Remission
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia
Contact: Study coordinator (Riad O El Fakih, MD)
Study leads
Riad O El Fakih, MD
Principal Investigator
KFSH&RC
Mahmoud D Aljurf, MD, MPH
Principal Investigator
KFSH&RC
Marwan Y Shaheen, MD
Principal Investigator
KFSH&RC